* Correspondence: Remigiusz Domin, [email protected] These authors have contributed equally to this work and share senior authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
J Immunol Res (2016) 2016:9064529
Bhunia S, Kolishetti N, Vashist A, Yndart Arias A, Brooks D, Nair M
He has served on the editorial boards of eight medical and neurological journals and is currently associate editor of Surgical Neurology, and editorial board member of Neurological Research and The Physician and Sports Medicine journals
Whats happening now is like a large-scale, open-label, public human trial thats being done on these drugs, the long-term consequences of which we dont know, noted Phillips